Co-administration of melatonin reverses the Tin-protoporphyrin (SnPP) induced decline of Cytochrome P450 content in vivo in rats

Citation
R. Chandra et al., Co-administration of melatonin reverses the Tin-protoporphyrin (SnPP) induced decline of Cytochrome P450 content in vivo in rats, EUR J DRUG, 25(3-4), 2000, pp. 213-218
Citations number
20
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
ISSN journal
03787966 → ACNP
Volume
25
Issue
3-4
Year of publication
2000
Pages
213 - 218
Database
ISI
SICI code
0378-7966(200007/12)25:3-4<213:COMRTT>2.0.ZU;2-2
Abstract
Melatonin (N-acetyl-5 methoxytryptamine) is a low molecular weight antioxid ant and is an endogeneous defence system against the deleterious actions of the extremely reactive hydroxyl radical. Among the enzymes that participat e in the antioxidant functions is cytochrome P-450, a stalwart of the detox ification system in the body. Our results revealed that tin-protoporphyrin administration brought about a marked decline in cytochrome P-450 levels. T his decline was, however, reversed by the coadministration of the antioxida nt, melatonin. Thus, the enhanced antioxidant status in melatonin-treated r ats may act as a protective mediator of various pharmacological functions a ltered during tin-protoporphyrin (an antihyperbilirubemenic agent) administ ration to Wistar rats.